GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » EV-to-Revenue

Futura Medical (LSE:FUM) EV-to-Revenue : 36.10 (As of May. 19, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Futura Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Futura Medical's enterprise value is £111.96 Mil. Futura Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £3.10 Mil. Therefore, Futura Medical's EV-to-Revenue for today is 36.10.

The historical rank and industry rank for Futura Medical's EV-to-Revenue or its related term are showing as below:

LSE:FUM' s EV-to-Revenue Range Over the Past 10 Years
Min: -3.66   Med: 84.24   Max: 714.89
Current: 36.1

During the past 13 years, the highest EV-to-Revenue of Futura Medical was 714.89. The lowest was -3.66. And the median was 84.24.

LSE:FUM's EV-to-Revenue is ranked worse than
73.95% of 1044 companies
in the Biotechnology industry
Industry Median: 8.205 vs LSE:FUM: 36.10

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-19), Futura Medical's stock price is £0.397. Futura Medical's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01. Therefore, Futura Medical's PS Ratio for today is 36.09.


Futura Medical EV-to-Revenue Historical Data

The historical data trend for Futura Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical EV-to-Revenue Chart

Futura Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 808.92 - - - 22.30

Futura Medical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 22.30

Competitive Comparison of Futura Medical's EV-to-Revenue

For the Biotechnology subindustry, Futura Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Futura Medical's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Futura Medical's EV-to-Revenue falls into.



Futura Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Futura Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=111.961/3.101
=36.10

Futura Medical's current Enterprise Value is £111.96 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Futura Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £3.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Futura Medical  (LSE:FUM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Futura Medical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.397/0.011
=36.09

Futura Medical's share price for today is £0.397.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Futura Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Futura Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Futura Medical (LSE:FUM) Business Description

Traded in Other Exchanges
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines